Savient Pharmaceuticals (SVNT) Posts Q4 Loss of 44c/Sh., Misses Views
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Financial Fact:
Selling, general and administrative: 14.32M
Today's EPS Names:
ITG, MTEX, NSYS, More
Financial Fact:
Selling, general and administrative: 14.32M
Today's EPS Names:
ITG, MTEX, NSYS, More
Join SI Premium – FREE
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q4 EPS of ($0.44), $0.06 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $3.71 million versus the consensus estimate of $3.51 million.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Citi sees Birkenstock EPS beat, guidance lift on FX and lower share count
- Morgan Stanley Upgrades Oil India Ltd. (OINL:IN) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
